B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

STS

MOLECULAR TARGET

steroid sulfatase

UniProt: P08842NCBI Gene: 4124 compounds

STS (steroid sulfatase) is targeted by 4 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting STS

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1emate3.8948
2stx643.3327
3irosustat3.3026
4Dehydroepiandrosterone Sulfate0.691

About STS as a Drug Target

STS (steroid sulfatase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 4 compounds with documented STS interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

STS inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.